IL109691A - History of Rifamycin Converted at Position 63 Preparation and Pharmaceutical Preparations Containing Them - Google Patents
History of Rifamycin Converted at Position 63 Preparation and Pharmaceutical Preparations Containing ThemInfo
- Publication number
- IL109691A IL109691A IL10969194A IL10969194A IL109691A IL 109691 A IL109691 A IL 109691A IL 10969194 A IL10969194 A IL 10969194A IL 10969194 A IL10969194 A IL 10969194A IL 109691 A IL109691 A IL 109691A
- Authority
- IL
- Israel
- Prior art keywords
- formula
- compound
- rifamycin
- alkyl
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP93108337 | 1993-05-24 | ||
| EP93110315 | 1993-06-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL109691A0 IL109691A0 (en) | 1994-08-26 |
| IL109691A true IL109691A (en) | 1998-10-30 |
Family
ID=26133222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL10969194A IL109691A (en) | 1993-05-24 | 1994-05-19 | History of Rifamycin Converted at Position 63 Preparation and Pharmaceutical Preparations Containing Them |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5786350A (pt) |
| JP (1) | JP3566962B2 (pt) |
| KR (1) | KR100325562B1 (pt) |
| AT (1) | ATE206427T1 (pt) |
| AU (1) | AU687817B2 (pt) |
| CA (1) | CA2160243C (pt) |
| DE (1) | DE69428535T2 (pt) |
| DK (1) | DK0700399T3 (pt) |
| ES (1) | ES2164704T3 (pt) |
| IL (1) | IL109691A (pt) |
| PT (1) | PT700399E (pt) |
| WO (1) | WO1994028002A1 (pt) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60234057D1 (de) | 2001-07-25 | 2009-11-26 | Raptor Pharmaceutical Inc | Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke |
| EP1453837A4 (en) * | 2001-11-21 | 2007-11-07 | Activbiotics Inc | TARGETED THERAPEUTIC AGENTS AND USES THEREOF |
| US7820652B2 (en) * | 2003-09-24 | 2010-10-26 | Activbiotics Pharma, Llc | Regimen for the administration of rifamycin-class antibiotics |
| WO2005070941A1 (en) * | 2004-01-13 | 2005-08-04 | Cumbre Pharmaceuticals Inc. | Rifamycin imino derivatives effective against drug-resistant microbes |
| US7247634B2 (en) * | 2004-01-13 | 2007-07-24 | Cumbre Pharmaceuticals Inc. | Rifamycin derivatives effective against drug-resistant microbes |
| US7256187B2 (en) | 2004-03-10 | 2007-08-14 | Cumbre Pharmaceuticals Inc. | Rifamycin C-11 oxime derivatives effective against drug-resistant microbes |
| US7265107B2 (en) | 2004-03-10 | 2007-09-04 | Cumbre Pharmaceuticals Inc. | Rifamycin C-11 oxime cyclo derivatives effective against drug-resistant microbes |
| US7250413B2 (en) * | 2004-04-26 | 2007-07-31 | Cumbre Pharmaceuticals Inc. | C-25 carbamate rifamycin derivatives with activity against drug-resistant microbes |
| WO2006012470A1 (en) | 2004-07-22 | 2006-02-02 | Cumbre Pharmaceuticals Inc. | Rifamycin derivatives for treating microbial infections |
| SI1889198T1 (sl) | 2005-04-28 | 2015-02-27 | Proteus Digital Health, Inc. | Farma-informacijski sistem |
| MX2009002893A (es) | 2006-09-18 | 2009-07-10 | Raptor Pharmaceutical Inc | Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap). |
| WO2010095940A2 (en) | 2009-02-20 | 2010-08-26 | To-Bbb Holding B.V. | Glutathione-based drug delivery system |
| NZ596876A (en) | 2009-05-06 | 2014-01-31 | Lab Skin Care Inc | Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
| WO2014043320A1 (en) * | 2012-09-12 | 2014-03-20 | Salix Pharmaceuticals, Inc. | Methods of administering rifaximin without producing antibiotic resistance |
| SG11202006994XA (en) | 2018-01-24 | 2020-08-28 | Univ Rockefeller | Antibacterial compounds, compositions thereof, and methods using same |
| EP4003200A4 (en) | 2019-07-23 | 2023-08-02 | The Rockefeller University | ANTIBACTERIAL COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF USE THEREOF |
| WO2024068926A1 (en) | 2022-09-30 | 2024-04-04 | BioVersys AG | Rifabutin analogs for the treatment of disease |
-
1994
- 1994-05-05 DK DK94916937T patent/DK0700399T3/da active
- 1994-05-05 JP JP50015095A patent/JP3566962B2/ja not_active Expired - Lifetime
- 1994-05-05 US US08/792,035 patent/US5786350A/en not_active Expired - Lifetime
- 1994-05-05 PT PT94916937T patent/PT700399E/pt unknown
- 1994-05-05 DE DE69428535T patent/DE69428535T2/de not_active Expired - Lifetime
- 1994-05-05 WO PCT/EP1994/001428 patent/WO1994028002A1/en active IP Right Grant
- 1994-05-05 CA CA002160243A patent/CA2160243C/en not_active Expired - Lifetime
- 1994-05-05 AT AT94916937T patent/ATE206427T1/de active
- 1994-05-05 AU AU68430/94A patent/AU687817B2/en not_active Expired
- 1994-05-05 ES ES94916937T patent/ES2164704T3/es not_active Expired - Lifetime
- 1994-05-05 KR KR1019950705232A patent/KR100325562B1/ko not_active IP Right Cessation
- 1994-05-19 IL IL10969194A patent/IL109691A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PT700399E (pt) | 2002-02-28 |
| DE69428535T2 (de) | 2002-08-01 |
| WO1994028002A1 (en) | 1994-12-08 |
| DE69428535D1 (de) | 2001-11-08 |
| AU6843094A (en) | 1994-12-20 |
| JP3566962B2 (ja) | 2004-09-15 |
| DK0700399T3 (da) | 2001-11-26 |
| CA2160243A1 (en) | 1994-12-08 |
| ATE206427T1 (de) | 2001-10-15 |
| KR100325562B1 (ko) | 2002-07-22 |
| JPH08511249A (ja) | 1996-11-26 |
| IL109691A0 (en) | 1994-08-26 |
| AU687817B2 (en) | 1998-03-05 |
| US5786350A (en) | 1998-07-28 |
| CA2160243C (en) | 2007-08-28 |
| KR960702466A (ko) | 1996-04-27 |
| ES2164704T3 (es) | 2002-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5786350A (en) | 36-derivatives of rifamycins and their use as antimicrobial agents | |
| JPH02231475A (ja) | 光学活性ピリドンカルボン酸誘導体 | |
| KR100491466B1 (ko) | 세팔로스포린 항생제 | |
| CA2723232C (en) | 5-hydroxymethyl-oxazolidin-2-one derivatives for treating bacterial intestinal diseases | |
| US5654318A (en) | Bicyclic amine derivatives | |
| JP2514136B2 (ja) | キノリジノン型化合物 | |
| US4921857A (en) | 4-Oxo-4h-quinolizine-3-carboxylic acids and derivatives thereof | |
| RU2100351C1 (ru) | Производные пиридонкарбоновой кислоты и композиция на их основе | |
| US4684644A (en) | Basic monocarboxyamide derivatives of actagardine having antibiotic activity and compositions thereof | |
| KR880001069B1 (ko) | 카르바페넴 유도체및 그의 제조방법 | |
| TW201211048A (en) | Compounds with antibacterial activity against Clostridium | |
| EP0700399B1 (en) | 36-derivatives of rifamycins and their use as antimicrobial agents | |
| US5116832A (en) | Penem derivatives production and use thereof | |
| EP0306860A2 (en) | 4-Oxo-3-Quinolinecarboxylic acids useful as antibacterial agents and preparation thereof | |
| CA2549561C (en) | 36- derivatives of rifamycins | |
| JPS6233176A (ja) | １，４−ジヒドロ−４−オキソナフチリジン誘導体およびその塩 | |
| HU218789B (hu) | Rifamicin-36-származékok, ezeket tartalmazó gyógyászati készítmények és eljárás előállításukra | |
| CN1358183A (zh) | 喹啉羧酸衍生物或其盐 | |
| IE863277L (en) | Rifamycin derivatives | |
| EP0005140B1 (en) | Novel 4-desoxy-thiazolo (5,4-c) rifamycin derivatives and a process for preparing them | |
| CA2027778A1 (en) | Optically active thiazetoquinoline-3-carboxylic acid compound, method for preparation thereof, and a pharmaceutical composition comprising the same | |
| JPS61148179A (ja) | 新規ナフチリジン誘導体、そのエステルおよびその塩 | |
| JP4730879B2 (ja) | キガマイシノン類及びその製造方法、並びに、該キガマイシノン類を含む薬用組成物 | |
| JPH0245631B2 (pt) | ||
| WO2005030752A1 (ja) | ８−シアノキノロンカルボン酸誘導体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| EXP | Patent expired |